Suppr超能文献

耐多药细菌引起的脊椎椎间盘炎:单中心25例经验

Spondylodiscitis by drug-multiresistant bacteria: a single-center experience of 25 cases.

作者信息

Shiban Ehab, Janssen Insa, Wostrack Maria, Krieg Sandro M, Horanin Monika, Stoffel Michael, Meyer Bernhard, Ringel Florian

机构信息

Department of Neurosurgery, Klinikum rechts der Isar, Technische Universität München, Ismaninger Str. 22, Munich 81675, Germany.

Department of Neurosurgery, Klinikum rechts der Isar, Technische Universität München, Ismaninger Str. 22, Munich 81675, Germany; Department of Neurosurgery, Helios Kliniken, Lutherplaz 40, 47805 Krefeld, Germany.

出版信息

Spine J. 2014 Dec 1;14(12):2826-34. doi: 10.1016/j.spinee.2014.03.048. Epub 2014 Apr 4.

Abstract

BACKGROUND CONTEXT

Although the incidence of pyogenic spinal infections is increasing, the ideal treatment of spondylodiscitis is still a controversially discussed issue. Furthermore, the proportion of multiresistant bacteria in spondylodiscitis is increasing, and treatment recommendations or reported results are missing for this especially difficult subset of patients.

PURPOSE

The aim of this study is to evaluate the surgical outcome and the postoperative antibacterial treatment regime.

STUDY DESIGN

Retrospective case series.

PATIENT SAMPLE

Patients treated for a spondylodiscitis from multiresistant bacteria at our department between 2006 and 2011.

METHODS

Data were gathered through review of patients' case notes, relevant imaging, and electronic records. Magnetic resonance imaging of the whole spine including gadolinium (Gd)-enhanced T1 sequences and computed tomography scans of the affected regions were obtained in all cases.

OUTCOME MEASURES

C-reactive protein (CRP) and complete blood cell count were analyzed in all cases using routine laboratory techniques. Neurologic deficits were classified according to the American Spinal Injury Association (ASIA) impairment scale.

RESULTS

Twenty-five patients were identified (15 gram-positive and 10 gram-negative drug-multiresistant bacteria). The mean age at presentation was 66 years, and 14 patients were male (56%). All patients presented with pain, and a neurologic deficit was present in 11 (44%) cases. An epidural abscess was found in 11 (44%) cases. At admission, CRP was elevated in all cases with a mean of 13±9.2 mg/dL. The main source of infection was previous spine surgery (36%). All patients in this series underwent surgical debridement of the infection and instrumentation of the spine. Postoperative intravenous antibiotics were administered for 19±8.6 days followed by 3±0.3 months of oral antibiotic therapy. Eradication of the infection was achieved ultimately in all surviving patients. Out of 11 patients with neurologic deficits, 4 had a full recovery, 4 improved incompletely, and 3 remained unchanged after surgery.

CONCLUSIONS

Staged surgical immobilization and instrumentation and optimal debridement at the interdiscal space and spinal canal is a reliable approach to achieve complete healing of spinal infection with multiresistant bacteria. A period of intravenous antibiotic therapy of 2 to 3 weeks followed by a 3-month oral antibiotic therapy seems appropriate for most cases.

摘要

背景

尽管化脓性脊柱感染的发病率在上升,但脊椎椎间盘炎的理想治疗方法仍是一个备受争议的话题。此外,脊椎椎间盘炎中多重耐药菌的比例在增加,对于这一特别棘手的患者亚组,缺乏治疗建议或报告的结果。

目的

本研究的目的是评估手术结果和术后抗菌治疗方案。

研究设计

回顾性病例系列研究。

患者样本

2006年至2011年间在我院接受多重耐药菌所致脊椎椎间盘炎治疗的患者。

方法

通过查阅患者病历、相关影像学资料和电子记录收集数据。所有病例均进行了包括钆(Gd)增强T1序列的全脊柱磁共振成像以及受累区域的计算机断层扫描。

观察指标

所有病例均采用常规实验室技术分析C反应蛋白(CRP)和全血细胞计数。根据美国脊髓损伤协会(ASIA)损伤量表对神经功能缺损进行分类。

结果

共确定25例患者(15例革兰氏阳性菌和10例革兰氏阴性菌多重耐药)。就诊时的平均年龄为66岁,14例为男性(56%)。所有患者均有疼痛症状,11例(44%)存在神经功能缺损。11例(44%)发现硬膜外脓肿。入院时,所有病例的CRP均升高,平均为13±9.2mg/dL。感染的主要来源是既往脊柱手术(36%)。本系列所有患者均接受了感染的手术清创和脊柱内固定。术后静脉使用抗生素19±8.6天,随后口服抗生素治疗3±0.3个月。所有存活患者最终实现了感染清除。11例神经功能缺损患者中,4例完全恢复,4例部分改善,3例术后无变化。

结论

分阶段进行手术固定和内固定,并在椎间盘间隙和椎管进行最佳清创,是实现多重耐药菌所致脊柱感染完全愈合的可靠方法。大多数病例静脉使用抗生素2至3周,随后口服抗生素治疗3个月似乎是合适的。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验